Acrux
Rights acquired to commercialize contraceptive spray
Published in Law and Health Weekly, March 11th, 2006
Under the agreement, Acrux has a worldwide license from the Population Council to intellectual property covering the use of Nestorone with Acrux's patented metered-dose skin spray delivery technology (MDTS). Acrux will develop and commercialize Nestorone MDTS and has the right to sublicense to commercial partners.
In addition to commercial distribution of the product, Acrux (or its sublicensees) will make Nestorone MDTS available at reduced...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Connetics Corp.
Dermatology company names Freddie Park vice president, intellectual property - Endovasc, Inc.
Drugmaker gets notice of allowance for U.S. patent protecting its muscle mass technology - Finance
Longs Drug Stores reports preliminary total sales increase of 7.4% - Harvard School of Public Health
Replication-defective viruses safe and efficient for vaccines and vaccine vectors - Health Discovery Corp.
New U.S. patent covers SVM-based image analysis - Medicare
New survey shows approval of Medicare prescription drug benefit - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
